Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY TTM	FY NaN	FY NaN	FY NaN	FY NaN
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Drug Substance	100.50B
Drug Substance Growth	-11.90%
Finished Drug	22.04B
Finished Drug Growth	22.58%
Drug Ingredients	-
Drug Ingredients Growth	-

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY TTM	FY NaN	FY NaN	FY NaN	FY NaN
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
South Korea	122.54B
South Korea Growth	-7.20%